Gainetdinov was a Senior Researcher in the Department of Neuroscience and Brain Technologies at the Italian

the mechanisms of action and regulation of hormones and neurotransmitters and how they might underlie brain Bryan Roth (current) Dr. Ali Salahpour (2007) Dr. Lauren Sloksy (2020) Dr. Josh C Snyder (2012) Dr.

Remulate, a neuronal adhesion GPCR with a human ortholog linked to vascular malformations and blood-brain The human ortholog has been associated with vascular malformations and blood-brain barrier dysfunction

Beaulieu has pioneered work establishing a role for Beta-arrestin signaling in the brain in vivo and

Bryan Roth on the DARPA-funded effort to design a non-psychedelic psychedelic for depression — and why GPCR drug discovery is the biology, not the chemistry. << Back to podcast list Strategic Partner(s) Bryan Bryan leads a $26.9 Million project to create better psychiatric medications, among other things. Join me and learn more about Bryan and his work. Dr. Bryan Roth on the web UNC School of Medicine / Pharmacology Roth Lab Roth Leads $26.9 Million Project

intake regulation, and inflammation — within complex tissue environments including the pancreas and brain

emphasis on understanding how these receptors operate within complex tissues such as the pancreas and brain

shared an example she heard in a podcast about fecal transplants and the relationship between the gut, brain

Kim describes a personal inclination toward challenging research areas. It’s highly expressed in the brain and spinal cord. So Ashish introduced it as a potential project area, and it stuck with me. Dr.

“Your brain’s not a machine. Let it rest.

The ideal delta agonist, by her account, would be non-internalizing, brain-penetrant, long-half-life,

cells in an age of iPSC enthusiasm 30:40 — Cannabinoids, the entourage hypothesis, and THC in teenage brains

molecular logic of synapse formation and how adhesion molecules encode synaptic specificity in the brain graduate studies, Boucard left an enzymatic reaction on his bench over a weekend — called away for army Mexico City 03:43 The summer lab that changed everything — and why he turned down medical school 10:23 Army

persistent scientific questioning and collaborative networks accelerate GPCR innovation across disease areas Martin Marro leads the Cell Pharmacology group in the Diabetes, Obesity and Complications Therapeutic Area through roles at Novartis and Tectonic Therapeutic, contributing to projects across key therapeutic areas—spanning

All my formal training was in the area of signal transduction, and I continued to work on this area since

significant contribution to the understanding of agonist/ antagonist GPCR kinetic determinants in an area

Daniel Isom "Dan was born and raised in the Cleveland area.

an automated chimeric homology modeling pipeline for GPCRs and since have branched out to multiple areas

an automated chimeric homology modeling pipeline for GPCRs and since have branched out to multiple areas

signaling are regulated in a sex-selective manner and how this can influence drug discovery in the area

Suboptimal CRO Partnerships ❌ Stalled Pipeline Progression ❌ Uncertainty in GPCR Investments Advisory Focus Areas with a focused discussion of your current GPCR program and critical challenges, identifying precise areas

activity and function Capabilities span the key endpoints that describe how a receptor behaves Key areas

For this, we have worked in three main areas: the regulation of G protein-coupled receptor signaling

For this, we have worked in three main areas: the regulation of G protein-coupled receptor signaling

For this, we have worked in three main areas: the regulation of G protein-coupled receptor signaling

For this, we have worked in three main areas: the regulation of G protein-coupled receptor signaling

been named President of GPCR Therapeutics, USA, a newly incorporated Biotechnology company in the Bay Area

Mike's lab has two main areas of interest: 1) alternative polyadenylation as a targetable driver of pancreatic conversation ended with Yamina expressing interest in learning more about Mike's two main research areas

Book a Strategy Call → Our Core Support Areas Discovery Consulting & Strategy Expert guidance to de-risk

signaling are regulated in a sex-selective manner and how this can influence drug discovery in the area